The monocarboxylate transporter (MCT)-1 plays an important role in the transfer of monocarboxylate metabolites such as lactate, ketone bodies, and acetic acid. The present study revealed the selective localization of MCT1 in reticular cells of the murine lymph node. An intense MCT1 immunoreactivity was found in the reticular cells forming a cellular network together with sinuslining cells in the medullary sinuses and in cells covering the inside of subcapsular sinuses. Electron-microscopically, MCT1 was localized along the plasma membrane of the reticular cells. The medullary reticular cells vigorously ingested carboxylate-modified latex particles, but any reticular cells within the cortical lymphoid follicles and medullary cords neither expressed MCT1 nor incorporated latex particles. MCT1-immunoreactive reticular cells also expressed LYVE-1, which is a hyaluronan receptor abundant in both the lymphatic endothelium and hepatic sinusoidal epithelium. The selective localization of MCT1 and LYVE-1 suggests a high level of activity for lymphoid reticular cells in the uptake of carboxylate-modified and hyaluronate waste substances circulating in the body.
The monocarboxylate transporter (MCT)-1 is a predominant transmembrane transporter specific for monocarboxylates including lactate, ketone bodies, and acetic acid. It is widely distributed in various tissues, among which are the intestinal epithelium, blood-brain barrier, placental barrier, skeletal muscle fibers, and urinary tubules (5, 9) . MCT transports monocarboxylates across the plasma membrane in both inward and outward directions according to the concentration gradient of the monocarboxylates and H + (4) . Since MCT is engaged in the uptake and transfer of small molecules with a carboxylate residue, it has been discussed exclusively for its role in the movement of nutrients and metabolites. For example, the utilization of lactate and ketone bodies in the brain is very intense during the suckling period but decreases after weaning to reach adult values. In parallel with this energy utility, a higher expression of MCT1 in the endothelium of brain blood vessels is observed during the suckling period in rodents (12) . The present study is the first to reveal a selective localization of MCT1 in reticular cells of the lymph node along with its possible function for the elimination of exogenous particles. LYVE-1 (lymphatic vessel endothelial hyaluronan receptor), a receptor molecule for hyaluronic acid, is intensely expressed in the lymphatic endothelium and some macrophage lineages (2, 6, 14) . Immunohistochemistry for LYVE-1 can specifically detect lymphatic vessels in various tissues where the receptor is engaged in the uptake and transport of hyaluronan into the vessel lumen (14) . Besides lymphatic endothelial cells, the hepatic sinusoidal endothelium expresses LYVE-1 (10) and may function in munostained sections were counterstained with SyTO 13 (Invitrogen) for observation of their nuclei. For the silver-intensified immunogold method, cryostat sections from the lymph node were pretreated with a normal goat serum, incubated with the rabbit anti-LYVE-1 antibody (3 μg/mL) overnight, and subsequently reacted with goat anti-rabbit IgG covalently linked with 1-nm gold particles (1 : 200; Nanoprobes, Yaphank, NY). Following silver enhancement using a kit (HQ silver; Nanoprobes), the sections were osmicated, dehydrated, and directly embedded in Epon (Nisshin EM). Ultrathin sections were prepared and stained with both uranyl acetate and lead citrate for observation under an electron microscope (H-7100; Hitachi, Tokyo, Japan). The immunostaining using rabbit and chicken anti-MCT1 antibodies selectively labeled reticular cells in both medullary sinuses and marginal (subcapsular) sinuses of the mesenteric lymph node (Fig. 1) . Sinus-lining cells in the medullary sinuses were equally immunolabeled for MCT1. In the marginal sinuses, only the sinus endothelium covering the inner side of the sinuses expressed MCT1 (Fig. 1c) . Electron-microscopically, gold particles showing the existence of MCT1 were localized along the plasma membrane of reticular cells (Fig. 2) . The reticular cells possessed a narrow cytoplasm and long cytoplasmic processes which grasped collagen bundles. When exogenous particles were injected via Peyer's patches, the sinus reticular cells of the mesenteric lymph node actively ingested carboxylate-modified fluorescent latex particles of 20 nm in size (Fig. 3) . However, the uptake activity of the reticular cells was slight against non-modified exogenous particles such as carbon particles under normal conditions (data not shown) (see ref. 15 ). Reticular cells within the lymphoid follicles and medullary cords neither expressed MCT1 nor incorporated latex particles. Double immunostaining for MCT1 and LYVE-1 labeled same reticular cells in the mesenteric lymph node (Fig. 4) . According to the Aschoff's concept (1), reticular cells of the lymph node as well as the hepatic sinusoidal endothelium are important members of the reticulo-endothelial system (RES) specialized for the elimination of a large variety of substances from the circulation. Since van Furth's group demonstrated its powerful scavenger function (17) , the mononuclear phagocyte system (MPS) has replaced RES in the role of eliminating endogenous waste products and exogenous substances/particles. However, some modern histochemical and electron microscopic the uptake of hyaluronate and chondroitin sulfate circulating in the body, in agreement with the idea of "scavenger endothelial cells" (16) . Although it is known that the hepatic sinusoidal endothelium and macrophages express LYVE-1, its selective expression in reticular cells remains unknown. The present study also focuses on the co-localization of MCT1 and LYVE-1 in reticular cells of the lymph node. Adult female ddY mice, weighing about 25-28 g, were used in this study. For conventional immunohistochemistry using cryostat sections, five mice were perfused with a physiological saline through the heart under deep anesthesia, followed with 4% paraformaldehyde in 0.1 M phosphate buffer. The myenteric lymph node was dissected out and immersed in the same fixative for an additional 6 h. Using another six mice, carboxylate-modified latex particles of 20 nm in diameter (FluoSpheres, red [580/605]; Life Technologies, Eugene, OR) or India ink were injected into the Peyer's patches at a dose of 100 μL, and the myenteric lymph node was obtained 3 h after the injection. All experiments using animals were performed under protocols following the Guidelines for Animal Experimentation, Hokkaido University Graduate School of Medicine. The fixed tissues were dipped in 30% sucrose overnight at 4°C, embedded in OCT compound (Sakura FineTechnical Co. Ltd., Tokyo, Japan), and quickly frozen in liquid nitrogen. Frozen sections of a 10 μm thickness were mounted onto poly-L-lysine-coated glass slides and immersed in 0.01 M phosphate-buffered saline (PBS, pH 7.2) containing 0.3% Triton-X100 for 1 h. They were pretreated with a normal donkey serum and incubated with a rabbit antimouse MCT1 antibody (donated by Dr M. Watanabe, Hokkaido University) or a rabbit anti-mouse LYVE-1 antibody (AngioBio, Del Mar, CA) at a concentration of 1-2 μg/mL overnight, followed by incubation with Cy3-labeled anti-rabbit IgG (1 : 200 in dilution; Jackson ImmunoResearch, West Grove, PA). For double immunofluorescence, the samples were pretreated with the normal donkey serum and incubated with a mixture of chicken anti-rat MCT1 antibody (AB1286; Chemicon International, Temecula, CA) and rabbit anti-LYVE-1 antibody (2 μg/mL) overnight. The sites of antigen-antibody reaction were detected by incubation for 2 h with rhodamineconjugated anti-chicken IgY (Santa Cruz Biotechnology, Santa Cruz, CA) and AlexaFluor 488-labeled anti-rabbit IgG (Invitrogen, Carlsbad, CA). Stained samples were mounted with glycerin-PBS and observed under a confocal laser scanning microscope (Fluoview; Olympus, Tokyo, Japan). Some of im- sinus-lining reticular cells in the medulla of the lymph node could equally ingest the carboxy-modified latex particles under normal conditions. When we injected carbon particles via Peyer's patches, the ability of reticular cells to uptake was low, though this uptake ability increased after a lipopolysaccaride challenge (15) . The difference between carboxymodified particles and carbon particles may be partially due to the affinity of MCT1 to the carboxy moiety. Reticular cells in the cortex of the lymph node, except for those reticular cells facing the subcapsular sinuses, neither expressed MCT1 nor ingested exogenous particles. An early immunohistochemical study for LYVE-1 in humans simply described the localization of LYVE-1 in lymphatic vessels of the lymph node and in sinusoidal endothelial cells of the spleen (2, 11) . The present observation revealed a more detailed localization of LYVE-1 in the lymph node of mice: reticular cells with dendritic morphology and sinuscovering endothelial cells-both cell types possibly having the same origin and function-in the medulla of the lymph node predominantly expressed LYVE-1. The distribution of LYVE-1 in the liver and lymph node overlaps with that of stabilin-2, which was purified from rat hepatic sinusoidal endothelial cells as a hyaluronan-binding protein (3, 13) . In the mouse lymph node, the expression of stabilin-2 was detected in lymphatic endothelial cells lining all the sinuses, namely the subcapsular/marginal, intermediate, and medullary sinuses (3). In the murine spleen, stabilin-2 was described as specifically present in the sinusoidal endothelium of the red pulp (3), in contrast to LYVE-1 which was expressed mainly in numerous macrophages of the red pulp (18) . Although the localization of stabilin-2 and LYVE-1 in the lymph node and spleen is not identical, it is worth noting that both molecules are shared by most RES members. studies have reconfirmed the active uptake of administrated particles by the hepatic sinusoidal endothelium and lymphoid reticular cells (7, 15, 16) . Hepatic sinusoidal endothelial cells ingest circulating substances by the mechanism of receptor-mediated endocytosis, in agreement with a finding that the sinusoidal endothelium expresses some scavenging receptors for hyaluronan and chondroitin sulphate (16) . Thus, immunohistochemical studies have demonstrated the localization of hyaluronan-binding receptors such as CD44 (8), LYVE-1 (2), and stabilin-2 (13) in hepatic endothelial cells. Although the existence of scanvenger receptors in reticular cells remains unproven, the present study demonstrated two receptor/transporters, namely MCT1 and LYVE-1, expressed in the reticular cells of the lymph node. MCT1 is engaged in the excretion or uptake of monocarboxylates. The sinus reticular cells and In conclusion, reticular cells in the medullary sinuses of the lymph node are highly active in the uptake of antigens and exogenous substances. These cells belong to the RES together with hepatic sinusoidal endothelial cells. The MCT1 and LYVE-1 expressed in reticular cells may be involved in the uptake of exogenous and waste substances or particles which are frequently modified by metabolic reactions such as carboxylation.
